IP Verse

Incyte patent opposition analysis

CompanyCompetitive AnalysisCompany Patent Opposition Analysis

Latest oppositions filed by Incyte

Explore patent oppositions filed by Incyte against competitors, revealing strategic technology disputes and market positioning. Monitor opposition details, timelines, and disputed innovations to understand competitive dynamics and IP enforcement strategy.

Last updated on: Aug 28, 2025
Patent NumberTitleApplicantOpposition Date

Get instant updates on new opposition filings by the company

EP3450434
Deuterated Derivatives Of RuxolitinibCONCERT PHARMACEUTICALSNov 23, 2021

Latest patents of Incyte opposed by its competitors

Explore Incyte's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Aug 28, 2025
Patent NumberGrant DateTitleTotal Oppositions
EP3773593
May 15, 2024Treatment Of Hidradenitis Suppurativa Using Jak Inhibitors1
EP2919766
May 26, 2021Sustained-Release Dosage Forms Of Ruxolitinib4
EP3070090
Dec 12, 2018Use Of Salts Of The Janus Kinase Inhibitor (R)-3-(4-(7H-Pyrrolo[2,3-D]Pyrimidin-4-Yl)-1H- Pyrazol-1-Yl)-3- Cyclopentylpropanenitrile1
EP3184526
Oct 3, 2018Pyrrolo[2,3-D]Pyrimidine Derivatives As Janus Kinase Inhibitor1
EP2671882
Feb 21, 2018Pyrrolo[2,3-B]Pyridin-4-Yl-Amines And Pyrrolo[2M3-B]Pyrimidin-4-Yl-Amines As Janus Kinase Inhibitors1
EP3050882
Jan 31, 2018Piperidin-4-Yl Azetidine Derivatives As Jak1 Inhibitors1
EP2300455
Jul 19, 2017Salts Of 2-Fluoro-N-Methyl-4-[7-(Quinolin-6-Yl-Methyl) - Imidazo [1, 2-B] [1, 2, 4] Triazin-2-Yl] Benzamide And Processes Related To Preparing The Same1

Top competitors of Incyte

Top competitors of Incyte based on patent oppositions.